Articles dans des revues avec comité de lecture (191)
  1. 133. Awomoyi, A. A., Marchant, A., Howson, J. M. M., McAdam, K. P., Blackwell, J. M., & Newport, M. J. (2002). Interleukin-10, polymorphism in SLC11A1 (formerly NRAMP1), and susceptibility to tuberculosis. The Journal of infectious diseases, 186(12), 1808-1814. doi:10.1086/345920
  2. 134. van der Sande, M., Kidd, I. M., Goetghebuer, T., Martynoga, R. A., Magnusen, A., Allen, S., Weber, M., Fielding, K., Marchant, A., & Whittle, H. C. (2002). Severe respiratory syncytial virus infection in early life is associated with increased type 2 cytokine production in Gambian children. Clinical and experimental allergy, 32(10), 1430-1435. doi:10.1046/j.1365-2745.2002.01521.x
  3. 135. Vekemans, J., Ota, M. O., Wang, E. C. Y., Kidd, M., Borysiewicz, L. K., Whittle, H. C., McAdam, K. P., Morgan, G., & Marchant, A. (2002). T cell responses to vaccines in infants: defective IFNgamma production after oral polio vaccination. Clinical and experimental immunology, 127(3), 495-498. doi:10.1046/j.1365-2249.2002.01788.x
  4. 136. Ota, M. O., Vekemans, J., Schlegel-Haueter, S. E., Fielding, K., Sanneh, M., Kidd, M., Newport, M. J., Aaby, P., Whittle, H., Lambert, P.-H., McAdam, K. P., Siegrist, C.-A., & Marchant, A. (2002). Influence of Mycobacterium bovis bacillus Calmette-Guérin on antibody and cytokine responses to human neonatal vaccination. The Journal of immunology, 168(2), 919-925.
  5. 137. Byl, B., Clevenbergh, P., Kentos, A., Jacobs, F., Marchant, A., Vincent, J. L., & Thys, J.-P. (2001). Ceftazidime- and imipenem-induced endotoxin release during treatment of gram-negative infections. European journal of clinical microbiology & infectious diseases, 20(11), 804-807. doi:10.1007/s100960100609
  6. 138. Vekemans, J., Lienhardt, C., Sillah, J., Wheeler, J. G., Lahai, G. P., Doherty, M., Corrah, T., Andersen, P., McAdam, K. P., & Marchant, A. (2001). Tuberculosis contacts but not patients have higher gamma interferon responses to ESAT-6 than do community controls in The Gambia. Infection and immunity, 69(10), 6554-6557. doi:10.1128/IAI.69.10.6554-6557.2001
  7. 139. Vekemans, J., Amedei, A., Ota, M. O., D'Elios, M. M., Goetghebuer, T., Ismaili, J., Newport, M. J., Del Prete, G., Goldman, M., McAdam, K. P., & Marchant, A. (2001). Neonatal bacillus Calmette-Guérin vaccination induces adult-like IFN-gamma production by CD4+ T lymphocytes. European Journal of Immunology, 31(5), 1531-1535. doi:10.1002/1521-4141(200105)31:5<1531::AID-IMMU1531>3.0.CO;2-1
  8. 140. Marchant, A., Amedei, A., Azzurri, A., Vekemans, J., Benagiano, M., Tamburini, C., Lienhardt, C., Corrah, T., McAdam, K. P., Romagnani, S., D'Elios, M. M., & Del Prete, G. (2001). Polarization of PPD-specific T-cell response of patients with tuberculosis from Th0 to Th1 profile after successful antimycobacterial therapy or in vitro conditioning with interferon-alpha or interleukin-12. American journal of respiratory cell and molecular biology, 24(2), 187-194.
  9. 141. Goriely, S., De Wit, D., Flamand, V., Goldman, M., Vekemans, J., & Marchant, A. (2001). Les réponses immunes à la médiation cellulaire chez le nouveau-né: Vers de nouvelles stratégies vaccinales ciblant les cellules dendritiques. MS. Médecine sciences, 17, 1237-1241.
  10. 142. Vekemans, J., Ota, M. O., Goetghebuer, T., Newport, M. J., & Marchant, A. (2000). Immunisation of newborns in the tropics. Vaccine, 19(4-5), 387-392. doi:10.1016/S0264-410X(00)00182-1
  11. 143. Marchant, A. (2000). Serological markers of disease activity in tuberculosis and HIV infection. Clinical and experimental immunology, 122(1), 10-12. doi:10.1046/j.1365-2249.2000.01371.x
  12. 144. Marchant, A., & Newport, M. J. (2000). Prevention of infectious diseases by neonatal and early infantile immunization: prospects for the new millennium. Current opinion in infectious diseases, 13(3), 241-246.
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Suivant >>